Physician profile
Jing Chen
NPI 1487145447
$6,125.44
in general payments reported to CMS, 2019-2025
9 companies · $1,523 in 2025
The $1,523 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,025 · 2024: $2,578 · 2025: $1,523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,529 · Food and Beverage: $2,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,529.47 |
| Food and Beverage | $2,595.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,411.37 | 2023-2025 | Indigo System, Penumbra System |
| Terumo Medical Corporation | $1,742.63 | 2023 | Glidesheath Slender |
| Boston Scientific Corporation | $1,441.02 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Eluvia, Express Ld Iliac / Biliary |
| Bard Peripheral Vascular, INC. | $149.74 | 2024 | Venovo |
| Cordis US Corp. | $126.45 | 2023 | Mynx Control |
| Abbott Laboratories | $104.76 | 2024 | Jeti All In One Non-Sterile Kit |
| Stryker Corporation | $92.35 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sirtex Medical INC | $31.29 | 2024 | Sir-Spheres Microspheres |
| Depuy Synthes Sales INC. | $25.83 | 2025 | Trufill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jing Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.